As of 2025-05-29, the EV/EBITDA ratio of Karuna Therapeutics Inc (KRTX) is -25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRTX's latest enterprise value is 12,397.19 mil USD. KRTX's TTM EBITDA according to its financial statements is -492.49 mil USD. Dividing these 2 quantities gives us the above KRTX EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.2x - 13.5x | 13.3x |
| Forward P/E multiples | 16.7x - 30.7x | 19.3x |
| Fair Price | (210.71) - (168.89) | (205.55) |
| Upside | -163.9% - -151.2% | -162.3% |
| Date | EV/EBITDA |